# IBCSG Trial 22-00 Serum Substudy

> **NCT02393833** · NA · TERMINATED · sponsor: **ETOP IBCSG Partners Foundation** · enrollment: 136 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Blood samples collection

## Key facts

- **NCT ID:** NCT02393833
- **Lead sponsor:** ETOP IBCSG Partners Foundation
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-06
- **Primary completion:** 2018-03-06
- **Final completion:** 2018-03-06
- **Target enrollment:** 136 (ACTUAL)
- **Why stopped:** Sufficient statistical power cannot be met due to low samples size
- **Last updated:** 2021-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02393833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02393833, "IBCSG Trial 22-00 Serum Substudy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02393833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*